FEATURED/ARCHIVES (02/05/24)
×
A Multinational, Multicenter, Randomized, Double-Blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients with Alzheimer’s Disease · June 2022
Articles
Journal of Clinical Neurology
×
Efficacy and Safety of Probiotics for the Treatment of Alzheimer’s Disease, Mild Cognitive Impairment, and Parkinson’s Disease: A Systematic Review and Meta-Analysis · February 2022
Articles
Frontiers in Aging Neuroscience
×
Dementia Risk After Major Elective Surgery Based on the Route of Anaesthesia: A Propensity Score-Matched Population-Based Cohort Study · November 2022
Articles
eClinicalMedicine
×
Association of Metformin Use with Alzheimer’s Disease in Patients with Newly Diagnosed Type 2 Diabetes: A Population-Based Nested Case-Control Study · December 2021
Articles
Scientific Reports
×
Treatment with the Direct Oral Anticoagulants (DOACs) Apixaban and Rivaroxaban Associated with Significant Worsening of Behavioural and Psychological Symptoms of Dementia (BPSD) · March 2021
Articles
BMJ Case Reports
×
Efficacy and Safety of Hypoglycemic Drugs in Improving Cognitive Function in Patients with Alzheimer’s Disease and Mild Cognitive Impairment: A Systematic Review and Network Meta-Analysis · November 2022
Articles
Frontiers in Neurology
×
Efficacy and Safety of Buyang-Huanwu-Tang (Boyang-Hwano-Tang) in Patients with Vascular Dementia: A Systematic Review and Meta-Analysis · February 2022
Articles
Complementary Therapies in Clinical Practice
×
Chemotherapy and the Risk of Alzheimer’s Disease in Colorectal Cancer Survivors: Evidence from the Medicare System · February 2021
Articles
JCO Oncology Practice
×
Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data from the Systolic Blood Pressure Intervention Trial (SPRINT) · July 2022
Articles
JAMA Network Open
×
The Association between Gabapentin or Pregabalin Use and the Risk of Dementia: An Analysis of the National Health Insurance Research Database in Taiwan · May 2023
Articles
Frontiers in Pharmacology
×
Acetylcholinesterase Inhibitors and Risk of Bleeding and Acute Ischemic Events in Non-Hypertensive Alzheimer’s Patients · August 2021
Articles
Alzheimer’s and Dementia: Translational Research and Clinical Interventions
×
Clinical Use of Acid Suppressants and Risk of Dementia in the Elderly: A Pharmaco-Epidemiological Cohort Study · November 2020
Articles
International Journal of Environmental Research and Public Health
×
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer’s Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial · April 2022
Articles
Journal of Alzheimer’s Disease
×
Safety and Biomarker Effects of Candesartan in Non-Hypertensive Adults with Prodromal Alzheimer’s Disease · October 2022
Articles
Brain Communications
×
Pioglitazone Use Increases Risk of Alzheimer’s Disease in Patients with Type 2 Diabetes Receiving Insulin · April 2023
Articles
Scientific Reports
×
Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults with Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials · September 2022
Articles
JAMA Neurology
×
A Delicate Balance: Psychotropic Polypharmacy and Anti-Cholinergic Use Are Correlated with Fall Incidence in Australian Inpatients with Dementia · August 2021
Articles
Aging Medicine
×
Proton Pump Inhibitors and Dementia: What Association? · May 2023
Articles
Dementia and Neuropsychologia